Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.3.0.814
Consolidated Balance Sheets - USD ($)
Jun. 30, 2015
Dec. 31, 2014
Current Assets    
Cash and cash equivalents $ 2,371,266 $ 4,220,225
Restricted cash 325,505 325,181
Accounts receivable - project revenue and reimbursable project costs 247,144 469,086
Prepaid expenses and other current assets 203,795 205,185
Total Current Assets 3,147,710 5,219,677
Property Plant and Equipment -net 0 0
Other Assets    
Patent costs 883,775 833,560
Total Assets 4,031,485 6,053,237
Current Liabilities    
Accounts payable and accrued liabilities 452,571 653,669
Total Current Liabilities 452,571 653,669
Warrant liability 2,975,061 4,633,312
Total Liabilities $ 3,427,632 $ 5,286,981
Commitments and contingencies
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding $ 0 $ 0
Common stock, $0.001 par value, 500,000,000 authorized, 18,082,874 shares outstanding at June 30, 2015 and December 31, 2014 18,083 18,083
Additional paid-in capital 71,541,403 70,801,464
Accumulated Deficit (70,955,633) (70,053,291)
Total Stockholders' Equity 603,853 766,256
Total Liabilities and Stockholders' Equity $ 4,031,485 $ 6,053,237